Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - Cash on Hand
Cash on Hand as of December 2023 : $0.44 B
According to Allogene Therapeutics
's latest financial reports the company has $0.44 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Allogene Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.51 B | 13.12% |
| 2021-12-31 | $0.45 B | -44.76% |
| 2020-12-31 | $0.82 B | 56.05% |
| 2019-12-31 | $0.53 B | 15.49% |
| 2018-12-31 | $0.45 B | |
| 2017-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -53.60% | 🇺🇸 USA |